Industry Research Reports

Home > Reports > Chemical & Material > Global Pharmaceutical Activated Carbon Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Pharmaceutical Activated Carbon Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-07-31

Pages: 125 Pages

Report ld: 4807099

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Pharmaceutical Activated Carbon market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Activated charcoal has been used as an oral medicine for a long time, and in the rescue and treatment of patients with acute transoral poisoning, medicinal activated charcoal is one of the important basic rescue measures, which can obviously reduce the absorption of poison and increase the excretion and removal of poison, and obviously improve the success rate of rescue of patients with transoral poisoning. Oral administration of activated carbon is an effective method to reduce the absorption of poisons taken by patients. As an excellent adsorbent material, activated carbon is not only used for oral adsorption and detoxification in emergency medicine, but also widely used as a blood perfusion adsorbent for artificial organ adsorption preparations, for specific central nervous system, for treating certain previously incurable diseases, and in recent years it has also been used as a drug carrier for solutes, for treating malignant tumors Lymph nodes, for guiding the removal of metastatic lymph nodes, and for adjust the pore size of activated carbon and its distribution so that it can absorb various harmful substances and bacteria.

Units: The units in this report refer to the basic quantity units of statistics, such as tablets (Changtian Pharmaceuticals) for the tablet type, and capsules and pills for the pill type, such as Wuxi Ji Yu Shanhe Pharmaceuticals. The unit of product for bag type or granule type is bag.

The key manufacturers of pharmaceutical activated carbon in the Chinese market are Jemincare, Changtian Pharma, Kureha, Myvitamins, etc. The top two manufacturers account for 99% of the market share, with the largest manufacturer being Jemincare with 89%. Production areas are mainly located in Europe, China, Japan, etc. In terms of product type, activated carbon tablets/granules occupy the major market share, accounting for 90%, followed by activated carbon capsules, accounting for about 10%. In terms of application, the pharmacy channel is the top application area, accounting for 70% of the total, while the prescription channel accounts for 28%.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceutical Activated Carbon market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Distribution Channel, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Jemincare
Changtian Pharma
Kureha
Myvitamins

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Pharmaceutical Activated Carbon Capsule
Pharmaceutical Activated Carbon Tablet
Others

Segment by Application

Drug Stores
Prescription Drug

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Pharmaceutical Activated Carbon study scope, segments the market by Type and by Distribution Channel, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Distribution Channel, identifies emerging use cases, and profiles leading customers by region and by Distribution Channel.

Chapter 7: North America—breaks down sales and revenue by Type, by Distribution Channel and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Distribution Channel and manufacturers, flagging drivers and barriers.

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Distribution Channel, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 10: Central & South America—measures sales and revenue by Type, by Distribution Channel, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Distribution Channel, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Distribution Channel, by sales region SWOT analysis, and recent strategic developments.

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Pharmaceutical Activated Carbon: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Pharmaceutical Activated Carbon Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Pharmaceutical Activated Carbon Capsule

1.2.3 Pharmaceutical Activated Carbon Tablet

1.2.4 Others

1.3 Market Segmentation by Distribution Channel

1.3.1 Global Pharmaceutical Activated Carbon Market Size by Distribution Channel, 2020 VS 2024 VS 2031

1.3.2 Drug Stores

1.3.3 Prescription Drug

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Pharmaceutical Activated Carbon Revenue Estimates and Forecasts 2020-2031

2.2 Global Pharmaceutical Activated Carbon Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Pharmaceutical Activated Carbon Sales Estimates and Forecasts 2020-2031

2.4 Global Pharmaceutical Activated Carbon Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Pharmaceutical Activated Carbon Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Pharmaceutical Activated Carbon Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Pharmaceutical Activated Carbon Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Pharmaceutical Activated Carbon Capsule Market Size by Manufacturers

4.5.2 Pharmaceutical Activated Carbon Tablet Market Size by Manufacturers

4.5.3 Others Market Size by Manufacturers

4.6 Global Pharmaceutical Activated Carbon Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Pharmaceutical Activated Carbon Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Pharmaceutical Activated Carbon Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Pharmaceutical Activated Carbon Sales by Distribution Channel

6.1.1 Global Historical and Forecasted Sales by Distribution Channel (2020-2031)

6.1.2 Global Sales Market Share by Distribution Channel (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Pharmaceutical Activated Carbon Revenue by Distribution Channel

6.2.1 Global Historical and Forecasted Revenue by Distribution Channel (2020-2031)

6.2.2 Revenue Market Share by Distribution Channel (2020-2031)

6.3 Global Pricing Dynamics by Distribution Channel (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Distribution Channel

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Pharmaceutical Activated Carbon Sales and Revenue by Type (2020-2031)

7.4 North America Pharmaceutical Activated Carbon Sales and Revenue by Distribution Channel (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Pharmaceutical Activated Carbon Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Pharmaceutical Activated Carbon Sales and Revenue by Type (2020-2031)

8.4 Europe Pharmaceutical Activated Carbon Sales and Revenue by Distribution Channel (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Pharmaceutical Activated Carbon Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Pharmaceutical Activated Carbon Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Pharmaceutical Activated Carbon Sales and Revenue by Distribution Channel (2020-2031)

9.5 Asia-Pacific Pharmaceutical Activated Carbon Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Pharmaceutical Activated Carbon Sales and Revenue by Type (2020-2031)

10.4 Central and South America Pharmaceutical Activated Carbon Sales and Revenue by Distribution Channel (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Pharmaceutical Activated Carbon Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Pharmaceutical Activated Carbon Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Pharmaceutical Activated Carbon Sales and Revenue by Distribution Channel (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Pharmaceutical Activated Carbon Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Jemincare

12.1.1 Jemincare Corporation Information

12.1.2 Jemincare Business Overview

12.1.3 Jemincare Pharmaceutical Activated Carbon Product Models, Descriptions and Specifications

12.1.4 Jemincare Pharmaceutical Activated Carbon Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Jemincare Pharmaceutical Activated Carbon Sales by Product in 2024

12.1.6 Jemincare Pharmaceutical Activated Carbon Sales by Distribution Channel in 2024

12.1.7 Jemincare Pharmaceutical Activated Carbon Sales by Geographic Area in 2024

12.1.8 Jemincare Pharmaceutical Activated Carbon SWOT Analysis

12.1.9 Jemincare Recent Developments

12.2 Changtian Pharma

12.2.1 Changtian Pharma Corporation Information

12.2.2 Changtian Pharma Business Overview

12.2.3 Changtian Pharma Pharmaceutical Activated Carbon Product Models, Descriptions and Specifications

12.2.4 Changtian Pharma Pharmaceutical Activated Carbon Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Changtian Pharma Pharmaceutical Activated Carbon Sales by Product in 2024

12.2.6 Changtian Pharma Pharmaceutical Activated Carbon Sales by Distribution Channel in 2024

12.2.7 Changtian Pharma Pharmaceutical Activated Carbon Sales by Geographic Area in 2024

12.2.8 Changtian Pharma Pharmaceutical Activated Carbon SWOT Analysis

12.2.9 Changtian Pharma Recent Developments

12.3 Kureha

12.3.1 Kureha Corporation Information

12.3.2 Kureha Business Overview

12.3.3 Kureha Pharmaceutical Activated Carbon Product Models, Descriptions and Specifications

12.3.4 Kureha Pharmaceutical Activated Carbon Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Kureha Pharmaceutical Activated Carbon Sales by Product in 2024

12.3.6 Kureha Pharmaceutical Activated Carbon Sales by Distribution Channel in 2024

12.3.7 Kureha Pharmaceutical Activated Carbon Sales by Geographic Area in 2024

12.3.8 Kureha Pharmaceutical Activated Carbon SWOT Analysis

12.3.9 Kureha Recent Developments

12.4 Myvitamins

12.4.1 Myvitamins Corporation Information

12.4.2 Myvitamins Business Overview

12.4.3 Myvitamins Pharmaceutical Activated Carbon Product Models, Descriptions and Specifications

12.4.4 Myvitamins Pharmaceutical Activated Carbon Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Myvitamins Pharmaceutical Activated Carbon Sales by Product in 2024

12.4.6 Myvitamins Pharmaceutical Activated Carbon Sales by Distribution Channel in 2024

12.4.7 Myvitamins Pharmaceutical Activated Carbon Sales by Geographic Area in 2024

12.4.8 Myvitamins Pharmaceutical Activated Carbon SWOT Analysis

12.4.9 Myvitamins Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Pharmaceutical Activated Carbon Industry Chain

13.2 Pharmaceutical Activated Carbon Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Pharmaceutical Activated Carbon Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Pharmaceutical Activated Carbon Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Pharmaceutical Activated Carbon Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Pharmaceutical Activated Carbon Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Pharmaceutical Activated Carbon Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Pharmaceutical Activated Carbon Market Size Growth Rate by Distribution Channel, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Pharmaceutical Activated Carbon Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Pharmaceutical Activated Carbon Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Pharmaceutical Activated Carbon Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Pharmaceutical Activated Carbon Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (M Units)

Table 7. Global Pharmaceutical Activated Carbon Sales by Region (2020-2025) & (M Units)

Table 8. Global Pharmaceutical Activated Carbon Sales by Region (2026-2031) & (M Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Pharmaceutical Activated Carbon Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (M Units)

Table 11. Global Pharmaceutical Activated Carbon Production by Region (2020-2025) & (M Units)

Table 12. Global Pharmaceutical Activated Carbon Production by Region (2026-2031) & (M Units)

Table 13. Global Pharmaceutical Activated Carbon Sales by Manufacturers (2020-2025) & (M Units)

Table 14. Global Pharmaceutical Activated Carbon Sales Share by Manufacturers (2020-2025)

Table 15. Global Pharmaceutical Activated Carbon Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Pharmaceutical Activated Carbon Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Pharmaceutical Activated Carbon by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Activated Carbon as of 2024)

Table 19. Global Pharmaceutical Activated Carbon Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Pharmaceutical Activated Carbon Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 21. Key Manufacturers Pharmaceutical Activated Carbon Manufacturing Base and Headquarters

Table 22. Global Pharmaceutical Activated Carbon Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Pharmaceutical Activated Carbon Sales by Type (2020-2025) & (M Units)

Table 26. Global Pharmaceutical Activated Carbon Sales by Type (2026-2031) & (M Units)

Table 27. Global Pharmaceutical Activated Carbon Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Pharmaceutical Activated Carbon Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Pharmaceutical Activated Carbon ASP by Type (2020-2031) & (US$/Unit)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Pharmaceutical Activated Carbon Sales by Distribution Channel (2020-2025) & (M Units)

Table 32. Global Pharmaceutical Activated Carbon Sales by Distribution Channel (2026-2031) & (M Units)

Table 33. Pharmaceutical Activated Carbon High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Pharmaceutical Activated Carbon Revenue by Distribution Channel (2020-2025) & (US$ Million)

Table 35. Global Pharmaceutical Activated Carbon Revenue by Distribution Channel (2026-2031) & (US$ Million)

Table 36. Global Pharmaceutical Activated Carbon ASP by Distribution Channel (2020-2031) & (US$/Unit)

Table 37. Top Customers by Region

Table 38. Top Customers by Distribution Channel

Table 39. North America Pharmaceutical Activated Carbon Growth Accelerators and Market Barriers

Table 40. North America Pharmaceutical Activated Carbon Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Pharmaceutical Activated Carbon Sales (M Units) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Pharmaceutical Activated Carbon Growth Accelerators and Market Barriers

Table 43. Europe Pharmaceutical Activated Carbon Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Pharmaceutical Activated Carbon Sales (M Units) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Pharmaceutical Activated Carbon Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Pharmaceutical Activated Carbon Sales (M Units) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Pharmaceutical Activated Carbon Growth Accelerators and Market Barriers

Table 48. Southeast Asia Pharmaceutical Activated Carbon Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Pharmaceutical Activated Carbon Investment Opportunities and Key Challenges

Table 50. Central and South America Pharmaceutical Activated Carbon Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Pharmaceutical Activated Carbon Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Pharmaceutical Activated Carbon Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Jemincare Corporation Information

Table 54. Jemincare Description and Major Businesses

Table 55. Jemincare Product Models, Descriptions and Specifications

Table 56. Jemincare Capacity, Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 57. Jemincare Sales Value Proportion by Product in 2024

Table 58. Jemincare Sales Value Proportion by Distribution Channel in 2024

Table 59. Jemincare Sales Value Proportion by Geographic Area in 2024

Table 60. Jemincare Pharmaceutical Activated Carbon SWOT Analysis

Table 61. Jemincare Recent Developments

Table 62. Changtian Pharma Corporation Information

Table 63. Changtian Pharma Description and Major Businesses

Table 64. Changtian Pharma Product Models, Descriptions and Specifications

Table 65. Changtian Pharma Capacity, Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 66. Changtian Pharma Sales Value Proportion by Product in 2024

Table 67. Changtian Pharma Sales Value Proportion by Distribution Channel in 2024

Table 68. Changtian Pharma Sales Value Proportion by Geographic Area in 2024

Table 69. Changtian Pharma Pharmaceutical Activated Carbon SWOT Analysis

Table 70. Changtian Pharma Recent Developments

Table 71. Kureha Corporation Information

Table 72. Kureha Description and Major Businesses

Table 73. Kureha Product Models, Descriptions and Specifications

Table 74. Kureha Capacity, Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Kureha Sales Value Proportion by Product in 2024

Table 76. Kureha Sales Value Proportion by Distribution Channel in 2024

Table 77. Kureha Sales Value Proportion by Geographic Area in 2024

Table 78. Kureha Pharmaceutical Activated Carbon SWOT Analysis

Table 79. Kureha Recent Developments

Table 80. Myvitamins Corporation Information

Table 81. Myvitamins Description and Major Businesses

Table 82. Myvitamins Product Models, Descriptions and Specifications

Table 83. Myvitamins Capacity, Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 84. Myvitamins Sales Value Proportion by Product in 2024

Table 85. Myvitamins Sales Value Proportion by Distribution Channel in 2024

Table 86. Myvitamins Sales Value Proportion by Geographic Area in 2024

Table 87. Myvitamins Pharmaceutical Activated Carbon SWOT Analysis

Table 88. Myvitamins Recent Developments

Table 89. Key Raw Materials Distribution

Table 90. Raw Materials Key Suppliers

Table 91. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 92. Milestones in Production Technology Evolution

Table 93. Distributors List

Table 94. Market Trends and Market Evolution

Table 95. Market Drivers and Opportunities

Table 96. Market Challenges, Risks, and Restraints

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Pharmaceutical Activated Carbon Product Picture

Figure 2. Global Pharmaceutical Activated Carbon Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Pharmaceutical Activated Carbon Capsule Product Picture

Figure 4. Pharmaceutical Activated Carbon Tablet Product Picture

Figure 5. Others Product Picture

Figure 6. Global Pharmaceutical Activated Carbon Market Size Growth Rate by Distribution Channel, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Drug Stores

Figure 8. Prescription Drug

Figure 9. Pharmaceutical Activated Carbon Report Years Considered

Figure 10. Global Pharmaceutical Activated Carbon Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 12. Global Pharmaceutical Activated Carbon Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Pharmaceutical Activated Carbon Revenue Market Share by Region (2020-2031)

Figure 14. Global Pharmaceutical Activated Carbon Sales (2020-2031) & (M Units)

Figure 15. Global Pharmaceutical Activated Carbon Sales (CAGR) by Region (2020-2031) (M Units)

Figure 16. Global Pharmaceutical Activated Carbon Sales Market Share by Region (2020-2031)

Figure 17. Global Pharmaceutical Activated Carbon Capacity, Production and Utilization (2020-2031) & (M Units)

Figure 18. Global Pharmaceutical Activated Carbon Production Trend by Region (2020-2031) (M Units)

Figure 19. Global Pharmaceutical Activated Carbon Production Market Share by Region (2020-2031)

Figure 20. Production Capacity Enablers & Constraints

Figure 21. Pharmaceutical Activated Carbon Production Growth Rate in North America (2020-2031) & (M Units)

Figure 22. Pharmaceutical Activated Carbon Production Growth Rate in Europe (2020-2031) & (M Units)

Figure 23. Pharmaceutical Activated Carbon Production Growth Rate in China (2020-2031) & (M Units)

Figure 24. Pharmaceutical Activated Carbon Production Growth Rate in Japan (2020-2031) & (M Units)

Figure 25. Top 5 and Top 10 Manufacturers Pharmaceutical Activated Carbon Sales Volume Market Share in 2024

Figure 26. Global Pharmaceutical Activated Carbon Revenue Market Share Ranking (2024)

Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 28. Pharmaceutical Activated Carbon Capsule Revenue Market Share by Manufacturer in 2024

Figure 29. Pharmaceutical Activated Carbon Tablet Revenue Market Share by Manufacturer in 2024

Figure 30. Others Revenue Market Share by Manufacturer in 2024

Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 33. Global Pharmaceutical Activated Carbon Sales Market Share by Type (2020-2031)

Figure 34. Global Pharmaceutical Activated Carbon Revenue Market Share by Type (2020-2031)

Figure 35. Global Pharmaceutical Activated Carbon Sales Market Share by Distribution Channel (2020-2031)

Figure 36. Global Pharmaceutical Activated Carbon Revenue Market Share by Distribution Channel (2020-2031)

Figure 37. North America Pharmaceutical Activated Carbon Sales YoY (2020-2031) & (M Units)

Figure 38. North America Pharmaceutical Activated Carbon Revenue YoY (2020-2031) & (US$ Million)

Figure 39. North America Top 5 Manufacturers Pharmaceutical Activated Carbon Sales Revenue (US$ Million) in 2024

Figure 40. North America Pharmaceutical Activated Carbon Sales Volume (M Units) by Type (2020- 2031)

Figure 41. North America Pharmaceutical Activated Carbon Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 42. North America Pharmaceutical Activated Carbon Sales Volume (M Units) by Distribution Channel (2020-2031)

Figure 43. North America Pharmaceutical Activated Carbon Sales Revenue (US$ Million) by Distribution Channel (2020-2031)

Figure 44. US Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 45. Canada Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 46. Mexico Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 47. Europe Pharmaceutical Activated Carbon Sales YoY (2020-2031) & (M Units)

Figure 48. Europe Pharmaceutical Activated Carbon Revenue YoY (2020-2031) & (US$ Million)

Figure 49. Europe Top 5 Manufacturers Pharmaceutical Activated Carbon Sales Revenue (US$ Million) in 2024

Figure 50. Europe Pharmaceutical Activated Carbon Sales Volume (M Units) by Type (2020-2031)

Figure 51. Europe Pharmaceutical Activated Carbon Sales Revenue (US$ Million) by Type (2020-2031)

Figure 52. Europe Pharmaceutical Activated Carbon Sales Volume (M Units) by Distribution Channel (2020-2031)

Figure 53. Europe Pharmaceutical Activated Carbon Sales Revenue (US$ Million) by Distribution Channel (2020-2031)

Figure 54. Germany Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 55. France Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 56. U.K. Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 57. Italy Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 58. Russia Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 59. Asia-Pacific Pharmaceutical Activated Carbon Sales YoY (2020-2031) & (M Units)

Figure 60. Asia-Pacific Pharmaceutical Activated Carbon Revenue YoY (2020-2031) & (US$ Million)

Figure 61. Asia-Pacific Top 8 Manufacturers Pharmaceutical Activated Carbon Sales Revenue (US$ Million) in 2024

Figure 62. Asia-Pacific Pharmaceutical Activated Carbon Sales Volume (M Units) by Type (2020- 2031)

Figure 63. Asia-Pacific Pharmaceutical Activated Carbon Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 64. Asia-Pacific Pharmaceutical Activated Carbon Sales Volume (M Units) by Distribution Channel (2020-2031)

Figure 65. Asia-Pacific Pharmaceutical Activated Carbon Sales Revenue (US$ Million) by Distribution Channel (2020-2031)

Figure 66. Indonesia Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 67. Japan Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 68. South Korea Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 69. China Taiwan Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 70. India Pharmaceutical Activated Carbon Revenue (2020-2031) & (US$ Million)

Figure 71. Central and South America Pharmaceutical Activated Carbon Sales YoY (2020-2031) & (M Units)

Figure 72. Central and South America Pharmaceutical Activated Carbon Revenue YoY (2020-2031) & (US$ Million)

Figure 73. Central and South America Top 5 Manufacturers Pharmaceutical Activated Carbon Sales Revenue (US$ Million) in 2024

Figure 74. Central and South America Pharmaceutical Activated Carbon Sales Volume (M Units) by Type (2021-2031)

Figure 75. Central and South America Pharmaceutical Activated Carbon Sales Revenue (US$ Million) by Type (2020-2031)

Figure 76. Central and South America Pharmaceutical Activated Carbon Sales Volume (M Units) by Distribution Channel (2020-2031)

Figure 77. Central and South America Pharmaceutical Activated Carbon Sales Revenue (US$ Million) by Distribution Channel (2020-2031)

Figure 78. Brazil Pharmaceutical Activated Carbon Revenue (2020-2025) & (US$ Million)

Figure 79. Argentina Pharmaceutical Activated Carbon Revenue (2020-2025) & (US$ Million)

Figure 80. Middle East, and Africa Pharmaceutical Activated Carbon Sales YoY (2020-2031) & (M Units)

Figure 81. Middle East and Africa Pharmaceutical Activated Carbon Revenue YoY (2020-2031) & (US$ Million)

Figure 82. Middle East and Africa Top 5 Manufacturers Pharmaceutical Activated Carbon Sales Revenue (US$ Million) in 2024

Figure 83. Middle East and Africa Pharmaceutical Activated Carbon Sales Volume (M Units) by Type (2021-2031)

Figure 84. South America Pharmaceutical Activated Carbon Sales Revenue (US$ Million) by Type (2020-2031)

Figure 85. Middle East and Africa Pharmaceutical Activated Carbon Sales Volume (M Units) by Distribution Channel (2020-2031)

Figure 86. Middle East and Africa Pharmaceutical Activated Carbon Sales Revenue (US$ Million) by Distribution Channel (2020-2031)

Figure 87. GCC Countries Pharmaceutical Activated Carbon Revenue (2020-2025) & (US$ Million)

Figure 88. Turkey Pharmaceutical Activated Carbon Revenue (2020-2025) & (US$ Million)

Figure 89. Egypt Pharmaceutical Activated Carbon Revenue (2020-2025) & (US$ Million)

Figure 90. South Africa Pharmaceutical Activated Carbon Revenue (2020-2025) & (US$ Million)

Figure 91. Pharmaceutical Activated Carbon Industry Chain Mapping

Figure 92. Regional Pharmaceutical Activated Carbon Manufacturing Base Distribution (%)

Figure 93. Pharmaceutical Activated Carbon Production Process

Figure 94. Regional Pharmaceutical Activated Carbon Production Cost Structure

Figure 95. Channels of Distribution (Direct Vs Distribution)

Figure 96. Bottom-up and Top-down Approaches for This Report

Figure 97. Data Triangulation

Figure 98. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pharmaceutical Activated Carbon market? zhanKai

The top companies in the global Pharmaceutical Activated Carbon market are Jemincare、Changtian Pharma、Kureha.

Related Reports

Global Pharmaceutical Activated Carbon Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Activated Carbon market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 70
USD 4250.00
(Single User License)
Global Pharmaceutical Activated Carbon Market Research Report 2026
The global Pharmaceutical Activated Carbon market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-05
Pages: 119
USD 2900.00
(Single User License)
Pharmaceutical Activated Carbon- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-05
Pages: 86
USD 3950.00
(Single User License)
Global Pharmaceutical Activated Carbon Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Activated Carbon market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 72
USD 4250.00
(Single User License)
Pharmaceutical Activated Carbon- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 86
USD 3950.00
(Single User License)
Global Pharmaceutical Activated Carbon Market Research Report 2025
The global market for Pharmaceutical Activated Carbon was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-19
Pages: 82
USD 2900.00
(Single User License)
Global Pharmaceutical Activated Carbon Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
The global Pharmaceutical Activated Carbon market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-04-17
Pages: 147
USD 5600.00
(Single User License)
Global Pharmaceutical Activated Carbon Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
The global Pharmaceutical Activated Carbon market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2024 and 2030.
Published Date: 2024-04-16
Pages: 132
USD 5900.00
(Single User License)
Global Pharmaceutical Activated Carbon Market Insights, Forecast to 2030
The global Pharmaceutical Activated Carbon market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-07
Pages: 74
USD 4900.00
(Single User License)
Pharmaceutical Activated Carbon - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 81
USD 3950.00
(Single User License)

Global Pharmaceutical Activated Carbon Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Activated Carbon market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 70
USD 4250.00 (Single User License)
Global Pharmaceutical Activated Carbon Market Research Report 2026
The global Pharmaceutical Activated Carbon market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-05
Pages: 119
USD 2900.00 (Single User License)
Pharmaceutical Activated Carbon- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-05
Pages: 86
USD 3950.00 (Single User License)
Global Pharmaceutical Activated Carbon Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Activated Carbon market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 72
USD 4250.00 (Single User License)
Pharmaceutical Activated Carbon- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 86
USD 3950.00 (Single User License)
Global Pharmaceutical Activated Carbon Market Research Report 2025
The global market for Pharmaceutical Activated Carbon was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-19
Pages: 82
USD 2900.00 (Single User License)
Global Pharmaceutical Activated Carbon Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
The global Pharmaceutical Activated Carbon market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-04-17
Pages: 147
USD 5600.00 (Single User License)
Global Pharmaceutical Activated Carbon Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
The global Pharmaceutical Activated Carbon market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2024 and 2030.
Published: 2024-04-16
Pages: 132
USD 5900.00 (Single User License)
Global Pharmaceutical Activated Carbon Market Insights, Forecast to 2030
The global Pharmaceutical Activated Carbon market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-07
Pages: 74
USD 4900.00 (Single User License)
Pharmaceutical Activated Carbon - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 81
USD 3950.00 (Single User License)